Literature DB >> 18708108

Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle.

S van Drunen Littel-van den Hurk1, A Luxembourg, B Ellefsen, D Wilson, A Ubach, D Hannaman, J V van den Hurk.   

Abstract

Despite the potential of DNA vaccines to induce strong, balanced immune responses in small experimental species, the immune responses to DNA immunization in larger species have generally been moderate and inconsistent. In this study, the TriGridtrade mark Delivery System (TDS), an electroporation-based DNA delivery platform, was evaluated for administration of DNA vaccines to calves. When compared to conventional intramuscular delivery, TDS-based delivery markedly and consistently enhanced gene expression from a plasmid encoding a reporter gene, secreted alkaline phosphatase, and improved cell-mediated and humoral immune responses to a plasmid encoding a model antigen, hepatitis B surface antigen. Importantly, the TDS-based procedure was well tolerated by the calves, which did not need to be anesthetized or sedated. These results suggest that the TDS is a useful delivery method for DNA vaccines in cattle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708108     DOI: 10.1016/j.vaccine.2008.07.093

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

2.  Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.

Authors:  Katherine H Liu; Mary A Ascenzi; Christine A Bellezza; Abraham J Bezuidenhout; Paul J Cote; Gloria Gonzalez-Aseguinolaza; Drew Hannaman; Alain Luxembourg; Claire F Evans; Bud C Tennant; Stephan Menne
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

3.  Two doses of bovine viral diarrhea virus DNA vaccine delivered by electroporation induce long-term protective immune responses.

Authors:  Sylvia van Drunen Littel-van den Hurk; Zoe Lawman; Marlene Snider; Don Wilson; Jan V van den Hurk; Barry Ellefsen; Drew Hannaman
Journal:  Clin Vaccine Immunol       Date:  2012-12-05

4.  Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults.

Authors:  Mark Wallace; Barbara Evans; Sandra Woods; Robin Mogg; Lei Zhang; Adam C Finnefrock; Dietmar Rabussay; Michael Fons; John Mallee; Devan Mehrotra; Florian Schödel; Luwy Musey
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

5.  Evaluation of a novel non-penetrating electrode for use in DNA vaccination.

Authors:  Amy Donate; Domenico Coppola; Yolmari Cruz; Richard Heller
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.

Authors:  Callie E Bounds; Steven A Kwilas; Ana I Kuehne; Jennifer M Brannan; Russell R Bakken; John M Dye; Jay W Hooper; Lesley C Dupuy; Barry Ellefsen; Drew Hannaman; Hua Wu; Jin-an Jiao; Eddie J Sullivan; Connie S Schmaljohn
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

7.  DNA vaccination for prostate cancer: key concepts and considerations.

Authors:  Grace Cole; Joanne McCaffrey; Ahlam A Ali; Helen O McCarthy
Journal:  Cancer Nanotechnol       Date:  2015-07-02

8.  Gene therapy by electroporation for the treatment of chronic renal failure in companion animals.

Authors:  Patricia A Brown; Angela M Bodles-Brakhop; Melissa A Pope; Ruxandra Draghia-Akli
Journal:  BMC Biotechnol       Date:  2009-01-16       Impact factor: 2.563

9.  A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.

Authors:  Thomas Eden; Stephan Menzel; Janusz Wesolowski; Philine Bergmann; Marion Nissen; Gudrun Dubberke; Fabienne Seyfried; Birte Albrecht; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Front Immunol       Date:  2018-01-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.